Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

James Woods

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Concepts & Ideas

Drug Dose-Response Relationship

Chemicals & Drugs

Procedures

Self Administration

Activities & Behaviors

Animal Behavior

Physiology

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
77
Winger, Gail
44
France, Charles
40
Traynor, John
35
Rice, Kenner
32
Ko, Mei-Chuan
30
Butelman, Eduardo
29
Medzihradsky, F
22
Lewis, John
19
Broadbear, Jillian
15
Young, Alice
15
Jutkiewicz, Emily
13
Koek, Wouter
13
Fantegrossi, William
12
Husbands, Stephen
11
Harris, Louis

Sign-in to see all Coauthors

Publications

TOP 3
Nieland Nick P R; Rennison David; Broadbear Jillian H; Purington Lauren; Woods James H; Traynor John R; Lewis John W; Husbands Stephen M
14beta-Arylpropiolylamino-17-cyclopropylmethyl-7,8-dihydronormorphinones and related opioids. further examples of pseudoirreversible mu opioid receptor antagonists.
Collins Gregory T; Brim Remy L; Narasimhan Diwahar; Ko Mei-Chuan; Sunahara Roger K; Zhan Chang-Guo; Woods James H
Cocaine esterase prevents cocaine-induced toxicity and the ongoing intravenous self-administration of cocaine in rats.
Collins Gregory T; Woods James H
Influence of conditioned reinforcement on the response-maintaining effects of quinpirole in rats.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of James Woods (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Nieland Nick P R; Rennison David; Broadbear Jillian H; Purington Lauren; Woods James H; Traynor John R; Lewis John W; Husbands Stephen M
14beta-Arylpropiolylamino-17-cyclopropylmethyl-7,8-dihydronormorphinones and related opioids. further examples of pseudoirreversible mu opioid receptor antagonists.
Journal of medicinal chemistry 2009;52(21):6926-30.
2009: Collins Gregory T; Brim Remy L; Narasimhan Diwahar; Ko Mei-Chuan; Sunahara Roger K; Zhan Chang-Guo; Woods James H
Cocaine esterase prevents cocaine-induced toxicity and the ongoing intravenous self-administration of cocaine in rats.
The Journal of pharmacology and experimental therapeutics 2009;331(2):445-55.
2009: Collins Gregory T; Woods James H
Influence of conditioned reinforcement on the response-maintaining effects of quinpirole in rats.
Behavioural pharmacology 2009;20(5-6):492-504.
2009: Jutkiewicz Emily M; Baladi Michelle G; Cooper Ziva D; Narasimhan Diwahar; Sunahara Roger K; Woods James H
A bacterial cocaine esterase protects against cocaine-induced epileptogenic activity and lethality.
Annals of emergency medicine 2009;54(3):409-20.
2009: Ko Mei-Chuan; Woods James H; Fantegrossi William E; Galuska Chad M; Wichmann Jürgen; Prinssen Eric P
Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(9):2088-96.
2009: Ko Mei-Chuan; Narasimhan Diwahar; Berlin Aaron A; Lukacs Nicholas W; Sunahara Roger K; Woods James H
Effects of cocaine esterase following its repeated administration with cocaine in mice.
Drug and alcohol dependence 2009;101(3):202-9.
2009: Collins Gregory T; Truccone Andrew; Haji-Abdi Faiza; Newman Amy Hauck; Grundt Peter; Rice Kenner C; Husbands Stephen M; Greedy Benjamin M; Enguehard-Gueiffier Cecile; Gueiffier Alain; Chen Jianyong; Wang Shaomeng; Katz Jonathan L; Grandy David K; Sunahara Roger K; Woods James H
Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice.
The Journal of pharmacology and experimental therapeutics 2009;329(1):210-7.
2009: Koffarnus Mikhail N; Greedy Benjamin; Husbands Stephen M; Grundt Peter; Newman Amy Hauck; Woods James H
The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats.
Psychopharmacology 2009;203(2):317-27.
2009: Moynihan H; Jales A R; Greedy B M; Rennison D; Broadbear J H; Purington L; Traynor J R; Woods J H; Lewis J W; Husbands S M
14 beta-O-cinnamoylnaltrexone and related dihydrocodeinones are mu opioid receptor partial agonists with predominant antagonist activity.
Journal of medicinal chemistry 2009;52(6):1553-7.
2008: Cooper Ziva D; Truong Yen Nhu-Thi; Shi Yong-Gong; Woods James H
Morphine deprivation increases self-administration of the fast- and short-acting mu-opioid receptor agonist remifentanil in the rat.
The Journal of pharmacology and experimental therapeutics 2008;326(3):920-9.
2008: Xie Hong; Woods James H; Traynor John R; Ko Mei-Chuan
The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.
Anesthesia and analgesia 2008;106(6):1873-81.
2008: Pascoe John E; Williams Keith L; Mukhopadhyay Partha; Rice Kenner C; Woods James H; Ko Mei-Chuan
Effects of mu, kappa, and delta opioid receptor agonists on the function of hypothalamic-pituitary-adrenal axis in monkeys.
Psychoneuroendocrinology 2008;33(4):478-86.
2008: Collins Gregory T; Calinski Diane M; Newman Amy Hauck; Grundt Peter; Woods James H
Food restriction alters N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effects.
The Journal of pharmacology and experimental therapeutics 2008;325(2):691-7.
2008: Koffarnus Mikhail N; Woods James H
Quantification of drug choice with the generalized matching law in rhesus monkeys.
Journal of the experimental analysis of behavior 2008;89(2):209-24.
2008: Jutkiewicz Emily M; Baladi Michelle G; Folk John E; Rice Kenner C; Woods James H
The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats.
The Journal of pharmacology and experimental therapeutics 2008;324(2):714-24.
2008: Fantegrossi W E; Ciullo J R; Wakabayashi K T; De La Garza R; Traynor J R; Woods J H
A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse.
Neuroscience 2008;151(2):533-43.
2008: Metcalf Matthew D; Aceto Mario D; Harris Louis S; Woods James H; Traynor John R; Coop Andrew; May Everette L
The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans.
Bioorganic & medicinal chemistry 2008;16(2):869-73.
2007: Collins Gregory T; Woods James H
Drug and reinforcement history as determinants of the response-maintaining effects of quinpirole in the rat.
The Journal of pharmacology and experimental therapeutics 2007;323(2):599-605.
2007: Wade-Galuska Tammy; Winger Gail; Woods James H
A behavioral economic analysis of cocaine and remifentanil self-administration in rhesus monkeys.
Psychopharmacology 2007;194(4):563-72.
2007: Chadman Kathryn K; Woods James H; Stitzel Jerry
Chlorisondamine inhibits the nicotine-induced stimulation of c-fos in the pigeon brain for up to 2 weeks.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2007;9(9):927-36.
2007: Lee Heeseung; Naughton Norah N; Woods James H; Ko Mei-Chuan
Effects of butorphanol on morphine-induced itch and analgesia in primates.
Anesthesiology 2007;107(3):478-85.
2007: Zhang Huina; Shi Yong-Gong; Woods James H; Watson Stanley J; Ko Mei-Chuan
Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies.
European journal of pharmacology 2007;570(1-3):89-96.
2007: Collins Gregory T; Newman Amy Hauck; Grundt Peter; Rice Kenner C; Husbands Stephen M; Chauvignac Cédric; Chen Jianyong; Wang Shaomeng; Woods James H
Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists.
Psychopharmacology 2007;193(2):159-70.
2007: Galuska Chad M; Wade-Galuska Tammy; Woods James H; Winger Gail
Fixed-ratio schedules of cocaine self-administration in rhesus monkeys: joint control of responding by past and upcoming doses.
Behavioural pharmacology 2007;18(2):171-5.
2007: Ko Mei-Chuan; Bowen Luvina D; Narasimhan Diwahar; Berlin Aaron A; Lukacs Nicholas W; Sunahara Roger K; Cooper Ziva D; Woods James H
Cocaine esterase: interactions with cocaine and immune responses in mice.
The Journal of pharmacology and experimental therapeutics 2007;320(2):926-33.
2007: Wade-Galuska Tammy; Galuska Chad M; Winger Gail; Woods James H
Aspartame demand in rhesus monkeys: effects of volume and concentration manipulations.
Behavioural processes 2007;74(1):71-8.
2006: Cooper Ziva D; Narasimhan Diwahar; Sunahara Roger K; Mierzejewski Pawel; Jutkiewicz Emily M; Larsen Nicholas A; Wilson Ian A; Landry Donald W; Woods James H
Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase.
Molecular pharmacology 2006;70(6):1885-91.
2006: Wood Susan K; Verhoeven Robert E; Savit Aaron Z; Rice Kenner C; Fischbach Peter S; Woods James H
Facilitation of cardiac vagal activity by CRF-R1 antagonists during swim stress in rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(12):2580-90.
2006: Galuska Chad M; Winger Gail; Hursh Steven R; Woods James H
Assessing unit-price related remifentanil choice in rhesus monkeys.
Journal of the experimental analysis of behavior 2006;86(2):181-95.
2006: Ko M C Holden; Wei Hui; Woods James H; Kennedy Robert T
Effects of intrathecally administered nociceptin/orphanin FQ in monkeys: behavioral and mass spectrometric studies.
The Journal of pharmacology and experimental therapeutics 2006;318(3):1257-64.
2006: Nieland Nick P R; Moynihan Humphrey A; Carrington Simon; Broadbear Jillian; Woods James H; Traynor John R; Husbands Stephen M; Lewis John W
Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphinones and codeinones.
Journal of medicinal chemistry 2006;49(17):5333-8.
2006: Winger G; Galuska C M; Hursh S R; Woods J H
Relative reinforcing effects of cocaine, remifentanil, and their combination in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 2006;318(1):223-9.
2006: Jutkiewicz Emily M; Baladi Michelle G; Folk John E; Rice Kenner C; Woods James H
The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol.
The Journal of pharmacology and experimental therapeutics 2006;317(3):1337-48.
2006: Zhang Huina; Torregrossa Mary M; Jutkiewicz Emily M; Shi Yong-Gong; Rice Kenner C; Woods James H; Watson Stanley J; Ko M C
Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects.
The European journal of neuroscience 2006;23(4):984-94.
2006: Jutkiewicz Emily M; Torregrossa Mary M; Sobczyk-Kojiro Katarzyna; Mosberg Henry I; Folk John E; Rice Kenner C; Watson Stanley J; Woods James H
Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects.
European journal of pharmacology 2006;531(1-3):151-9.
2006: Ko M C Holden; Divin Mary F; Lee Heeseung; Woods James H; Traynor John R
Differential in vivo potencies of naltrexone and 6beta-naltrexol in the monkey.
The Journal of pharmacology and experimental therapeutics 2006;316(2):772-9.
2006: Fantegrossi W E; Harrington A W; Kiessel C L; Eckler J R; Rabin R A; Winter J C; Coop A; Rice K C; Woods J H
Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.
Pharmacology, biochemistry, and behavior 2006;83(1):122-9.
2006: Torregrossa Mary M; Jutkiewicz Emily M; Mosberg Henry I; Balboni Gianfranco; Watson Stanley J; Woods James H
Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats.
Brain research 2006;1069(1):172-81.
2005: Fantegrossi William E; Kugle Kelly M; Valdes Leander J; Koreeda Masato; Woods James H
Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.
Behavioural pharmacology 2005;16(8):627-33.
2005: Winger Gail; Woods James H; Galuska Chad M; Wade-Galuska Tammy
Behavioral perspectives on the neuroscience of drug addiction.
Journal of the experimental analysis of behavior 2005;84(3):667-81.
2005: Torregrossa Mary M; Folk John E; Rice Kenner C; Watson Stanley J; Woods James H
Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats.
Psychopharmacology 2005;183(1):31-40.
2005: Jutkiewicz Emily M; Rice Kenner C; Traynor John R; Woods James H
Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats.
Psychopharmacology 2005;182(4):588-96.
2005: Jutkiewicz Emily M; Kaminsky Sarah T; Rice Kenner C; Traynor John R; Woods James H
Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats.
The Journal of pharmacology and experimental therapeutics 2005;315(1):414-22.
2005: Galuska Chad M; Woods James H
Acquisition of cocaine self-administration with unsignaled delayed reinforcement in rhesus monkeys.
Journal of the experimental analysis of behavior 2005;84(2):269-80.
2005: Fantegrossi William E; Kiessel Christina L; De la Garza Richard; Woods James H
Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse.
Psychopharmacology 2005;181(3):529-36.
2005: Fantegrossi William E; Harrington Andrew W; Eckler Justin R; Arshad Sadia; Rabin Richard A; Winter Jerrold C; Coop Andrew; Rice Kenner C; Woods James H
Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
Psychopharmacology 2005;181(3):496-503.
2005: Collins Gregory T; Witkin Jeffrey M; Newman Amy H; Svensson Kjell A; Grundt Peter; Cao Jianjing; Woods James H
Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
The Journal of pharmacology and experimental therapeutics 2005;314(1):310-9.
2005: Jutkiewicz Emily M; Wood Susan K; Houshyar Hani; Hsin Ling-Wei; Rice Kenner C; Woods James H
The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats.
Psychopharmacology 2005;180(2):215-23.
2005: Jutkiewicz Emily M; Walker Nicholas P; Folk John E; Rice Kenner C; Portoghese Philip S; Woods James H; Traynor John R
Comparison of peptidic and nonpeptidic delta-opioid agonists on guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding in brain slices from Sprague-Dawley rats.
The Journal of pharmacology and experimental therapeutics 2005;312(3):1314-20.
2005: Husbands Stephen M; Neilan Claire L; Broadbear Jillian; Grundt Peter; Breeden Simon; Aceto Mario D; Woods James H; Lewis John W; Traynor John R
BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism.
European journal of pharmacology 2005;509(2-3):117-25.
2005: Hursh Steven R; Galuska Chad M; Winger Gail; Woods James H
The economics of drug abuse: a quantitative assessment of drug demand.
Molecular interventions 2005;5(1):20-8.
2005: Fantegrossi W E; Ko M C H; Woods J H; Richelson E
Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys.
Pharmacology, biochemistry, and behavior 2005;80(2):341-9.
2005: Fantegrossi W E; Winger G; Woods J H; Woolverton W L; Coop A
Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys.
Drug and alcohol dependence 2005;77(2):161-8.
2005: Broadbear Jillian H; Winger Gail; Woods James H
Self-administration of methohexital, midazolam and ethanol: effects on the pituitary-adrenal axis in rhesus monkeys.
Psychopharmacology 2005;178(1):83-91.
2004: Broadbear Jillian H; Winger Gail; Woods James H
Self-administration of fentanyl, cocaine and ketamine: effects on the pituitary-adrenal axis in rhesus monkeys.
Psychopharmacology 2004;176(3-4):398-406.
2004: Neilan Claire L; Husbands Stephen M; Breeden Simon; Ko M C Holden; Aceto Mario D; Lewis John W; Woods James H; Traynor John R
Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
European journal of pharmacology 2004;499(1-2):107-16.
2004: Fantegrossi William E; Woolverton William L; Kilbourn Michael; Sherman Phillip; Yuan Jie; Hatzidimitriou George; Ricaurte George A; Woods James H; Winger Gail
Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(7):1270-81.
2004: Broadbear Jillian H; Winger Gail; Rivier Jean E; Rice Kenner C; Woods James H
Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(6):1112-21.
2004: Fantegrossi William E; Kiessel Christina Lynn; Leach P Tarn; Van Martin C; Karabenick Rachel Lynn; Chen X; Ohizumi Y; Ullrich Thomas; Rice Kenner C; Woods James H
Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice.
Psychopharmacology 2004;173(3-4):270-7.
2004: Williams Keith L; Broadbear Jillian H; Woods James H
Noncontingent and response-contingent intravenous ethanol attenuates the effect of naltrexone on hypothalamic-pituitary-adrenal activity in rhesus monkeys.
Alcoholism, clinical and experimental research 2004;28(4):566-71.
2004: Jutkiewicz Emily M; Eller Erik B; Folk John E; Rice Kenner C; Traynor John R; Woods James H
Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats.
The Journal of pharmacology and experimental therapeutics 2004;309(1):173-81.
2004: Torregrossa Mary M; Isgor Ceylan; Folk John E; Rice Kenner C; Watson Stanley J; Woods James H
The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(4):649-59.
2004: Fantegrossi W E; Woods J H; Winger G
Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys.
Behavioural pharmacology 2004;15(2):149-57.
2004: Chadman Kathryn K; Woods James H
Cardiovascular effects of nicotine, chlorisondamine, and mecamylamine in the pigeon.
The Journal of pharmacology and experimental therapeutics 2004;308(1):73-8.
2004: Wei Hui; Nolkrantz Kerstin; Powell David H; Woods James H; Ko Mei-Chuan; Kennedy Robert T
Electrospray sample deposition for matrix-assisted laser desorption/ionization (MALDI) and atmospheric pressure MALDI mass spectrometry with attomole detection limits.
Rapid communications in mass spectrometry : RCM 2004;18(11):1193-200.
2003: Jutkiewicz E M; Rice K C; Woods J H; Winsauer P J
Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats.
Behavioural pharmacology 2003;14(7):509-16.
2003: Lee H; Naughton N N; Woods J H; Ko M C H
Characterization of scratching responses in rats following centrally administered morphine or bombesin.
Behavioural pharmacology 2003;14(7):501-8.
2003: Ko M C H; Willmont K J; Lee H; Flory G S; Woods J H
Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys.
Brain research 2003;982(1):38-44.
2003: Ko M C H; Lee H; Harrison C; Clark M J; Song H F; Naughton N N; Woods J H; Traynor J R
Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
The Journal of pharmacology and experimental therapeutics 2003;306(1):179-86.
2003: Williams K L; Ko M C Holden; Rice K C; Woods J H
Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys.
Psychoneuroendocrinology 2003;28(4):513-28.
2003: Greiner Elisabeth; Spetea Mariana; Krassnig Roland; Schüllner Falko; Aceto Mario; Harris Louis S; Traynor John R; Woods James H; Coop Andrew; Schmidhammer Helmut
Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships.
Journal of medicinal chemistry 2003;46(9):1758-63.
2003: Ko M C Holden; Lee Heeseung; Song Michael S; Sobczyk-Kojiro Katarzyna; Mosberg Henry I; Kishioka Shiroh; Woods James H; Naughton Norah N
Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.
The Journal of pharmacology and experimental therapeutics 2003;305(1):173-9.
2003: Fantegrossi William E; Godlewski Tomek; Karabenick Rachel L; Stephens Jermaine M; Ullrich Thomas; Rice Kenner C; Woods James H
Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.
Psychopharmacology 2003;166(3):202-11.
2003: Flory Graham S; Woods James H
The ascending limb of the cocaine dose-response curve for reinforcing effect in rhesus monkeys.
Psychopharmacology 2003;166(1):91-4.
2003: May Everette L; Coop Andrew; Woods James H; Aceto Mario D; Bowman Edward R; Harris Louis S; Traynor John R
N-(trifluoromethyl)benzyl substituted N-normetazocines and N-norketobemidones.
Bioorganic & medicinal chemistry 2003;11(1):31-3.
2002: Broadbear Jillian H; Winger Gail; Rice Kenner C; Woods James H
Antalarmin, a putative CRH-RI antagonist, has transient reinforcing effects in rhesus monkeys.
Psychopharmacology 2002;164(3):268-76.
2002: Broom Daniel C; Nitsche Joshua F; Pintar John E; Rice Kenner C; Woods James H; Traynor John R
Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.
The Journal of pharmacology and experimental therapeutics 2002;303(2):723-9.
2002: Woods J H; France C P
Determinants of the behavioral effects of opioids and their antagonists: contributions of the Laboratory of Psychobiology.
Psychopharmacology 2002;163(3-4):406-11.
2002: Woods J H; Winger G D
Observing responses maintained by stimuli associated with cocaine or remifentanil reinforcement in rhesus monkeys.
Psychopharmacology 2002;163(3-4):345-51.
2002: Broom Daniel C; Jutkiewicz Emily M; Folk John E; Traynor John R; Rice Kenner C; Woods James H
Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats.
Psychopharmacology 2002;164(1):42-8.
2002: Broom Daniel C; Jutkiewicz Emily M; Rice Kenner C; Traynor John R; Woods James H
Behavioral effects of delta-opioid receptor agonists: potential antidepressants?
Japanese journal of pharmacology 2002;90(1):1-6.
2002: Fantegrossi William E; Ullrich Thomas; Rice Kenner C; Woods James H; Winger Gail
3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement.
Psychopharmacology 2002;161(4):356-64.
2002: Koetzner Lee; Woods James H
Characterization of equine butyrylcholinesterase disposition in the mouse.
Drug metabolism and disposition: the biological fate of chemicals 2002;30(6):724-30.
2002: Koetzner Lee; Woods James H
Characterization of butyrylcholinesterase antagonism of cocaine-induced hyperactivity.
Drug metabolism and disposition: the biological fate of chemicals 2002;30(6):716-23.
2002: Broom Daniel C; Jutkiewicz Emily M; Folk John E; Traynor John R; Rice Kenner C; Woods James H
Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(6):744-55.
2002: Ko M C; Terner J; Hursh S; Woods J H; Winger G
Relative reinforcing effects of three opioids with different durations of action.
The Journal of pharmacology and experimental therapeutics 2002;301(2):698-704.
2002: Winger G; Hursh S R; Casey K L; Woods J H
Relative reinforcing strength of three N-methyl-D-aspartate antagonists with different onsets of action.
The Journal of pharmacology and experimental therapeutics 2002;301(2):690-7.
2002: Ko M C H; Naughton N N; Traynor J R; Song M S; Woods J H; Rice K C; McKnight A T
Orphanin FQ inhibits capsaicin-induced thermal nociception in monkeys by activation of peripheral ORL1 receptors.
British journal of pharmacology 2002;135(4):943-50.
2002: Koetzner Lee; Sumpter Tina L; Woods James H
Tetrabenazine fails to antagonize a behavioral effect of cocaine in rhesus monkeys.
Pharmacology, biochemistry, and behavior 2002;71(1-2):1-5.
2002: Alt A; Clark M J; Woods J H; Traynor J R
Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells.
British journal of pharmacology 2002;135(1):217-25.
2001: Houshyar H; Galigniana M D; Pratt W B; Woods J H
Differential responsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress responses.
Journal of neuroendocrinology 2001;13(10):875-86.
2001: Houshyar H; Cooper Z D; Woods J H
Paradoxical effects of chronic morphine treatment on the temperature and pituitary-adrenal responses to acute restraint stress: a chronic stress paradigm.
Journal of neuroendocrinology 2001;13(10):862-74.
2001: Williams K L; Kane E C; Woods J H
Interaction of morphine and naltrexone on oral ethanol self-administration in rhesus monkeys.
Behavioural pharmacology 2001;12(5):325-33.
2001: Butelman E R; Ko M C; Traynor J R; Vivian J A; Kreek M J; Woods J H
GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 2001;298(3):1049-59.
2001: Alt A; McFadyen I J; Fan C D; Woods J H; Traynor J R
Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
The Journal of pharmacology and experimental therapeutics 2001;298(1):116-21.
2001: Briscoe R J; Jeanville P M; Cabrera C; Baird T J; Woods J H; Landry D W
A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis.
International immunopharmacology 2001;1(6):1189-98.
2001: Gerak L R; Woolverton W L; Nader M A; Patrick G A; Harris L S; Winger G; Woods J H; France C P
Behavioral effects of flunitrazepam: reinforcing and discriminative stimulus effects in rhesus monkeys and prevention of withdrawal signs in pentobarbital-dependent rats.
Drug and alcohol dependence 2001;63(1):39-49.
2001: Woods J H
How does regulation of drug intake come about? Comment on Lynch and Carroll (2001).
Experimental and clinical psychopharmacology 2001;9(2):155-6; discussion 160-2.
2001: Winger G; Woods J H
The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys.
Drug and alcohol dependence 2001;62(3):181-9.
2001: Koetzner L; Deng S; Sumpter T L; Weisslitz M; Abner R T; Landry D W; Woods J H
Titer-dependent antagonism of cocaine following active immunization in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 2001;296(3):789-96.
2000: May E L; Jacobson A E; Mattson M V; Traynor J R; Woods J H; Harris L S; Bowman E R; Aceto M D
Synthesis and in vitro and in vivo activity of (-)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-alkenyl-, -N-alkynyl-, and -N-cyanoalkyl-5, 9-dimethyl-2'-hydroxy-6,7-benzomorphan homologues.
Journal of medicinal chemistry 2000;43(26):5030-6.
2000: Baird T J; Deng S X; Landry D W; Winger G; Woods J H
Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats.
The Journal of pharmacology and experimental therapeutics 2000;295(3):1127-34.
2000: Coop A; Jacobson A E; Aceto M D; Harris L S; Traynor J R; Woods J H; Rice K C
N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindole.
Bioorganic & medicinal chemistry letters 2000;10(21):2449-51.
2000: Briscoe R J; Cabrera C L; Baird T J; Rice K C; Woods J H
Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats.
Brain research 2000;881(2):204-7.
2000: Jeanville P M; Woods J H; Baird T J; Estapé E S
Direct determination of ecgonine methyl ester and cocaine in rat plasma, utilizing on-line sample extraction coupled with rapid chromatography/quadrupole orthogonal acceleration time-of-flight detection.
Journal of pharmaceutical and biomedical analysis 2000;23(5):897-907.
2000: McFadyen I J; Houshyar H; Liu-Chen L Y; Woods J H; Traynor J R
The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: implications for the mu-opioid pharmacophore.
Molecular pharmacology 2000;58(4):669-76.
2000: Broom D C; Guo L; Coop A; Husbands S M; Lewis J W; Woods J H; Traynor J R
BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
The Journal of pharmacology and experimental therapeutics 2000;294(3):1195-200.
2000: Broadbear J H; Sumpter T L; Burke T F; Husbands S M; Lewis J W; Woods J H; Traynor J R
Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
The Journal of pharmacology and experimental therapeutics 2000;294(3):933-40.
2000: Zubieta J; Greenwald M K; Lombardi U; Woods J H; Kilbourn M R; Jewett D M; Koeppe R A; Schuster C R; Johanson C E
Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;23(3):326-34.
2000: Woods J H
The next reinforcer: comment on Meisch (2000)
Experimental and clinical psychopharmacology 2000;8(3):360-1; discussion 362-5.
2000: Derrick I; Neilan C L; Andes J; Husbands S M; Woods J H; Traynor J R; Lewis J W
3-Deoxyclocinnamox: the first high-affinity, nonpeptide mu-opioid antagonist lacking a phenolic hydroxyl group.
Journal of medicinal chemistry 2000;43(17):3348-50.
2000: Ko M C; Willmont K J; Burritt A; Hruby V J; Woods J H
Local inhibitory effects of dynorphin A-(1-17) on capsaicin-induced thermal allodynia in rhesus monkeys.
European journal of pharmacology 2000;402(1-2):69-76.
2000: Williams K L; Woods J H
A behavioral economic analysis of concurrent ethanol- and water-reinforced responding in different preference conditions.
Alcoholism, clinical and experimental research 2000;24(7):980-6.
2000: Kishioka1 S; Paronis2 C A; Woods J H
Acute dependence on, but not tolerance to, heroin and morphine as measured by respiratory effects in rhesus monkeys.
European journal of pharmacology 2000;398(1):121-30.
2000: Kishioka S; Ko M C; Woods J H
Diltiazem enhances the analgesic but not the respiratory depressant effects of morphine in rhesus monkeys.
European journal of pharmacology 2000;397(1):85-92.
2000: Remmers A E; Clark M J; Alt A; Medzihradsky F; Woods J H; Traynor J R
Activation of G protein by opioid receptors: role of receptor number and G-protein concentration.
European journal of pharmacology 2000;396(2-3):67-75.
2000: Houshyar H; Mc Fadyen I J; Woods J H; Traynor J R
Antinociceptive and other behavioral effects of the steroid SC17599 are mediated by the mu-opioid receptor.
European journal of pharmacology 2000;395(2):121-8.
2000: Briscoe R J; Winger G; Lewis J W; Woods J H
Methoclocinnamox: time course of changes in alfentanil-reinforced responding in rhesus monkeys.
Psychopharmacology 2000;148(4):393-9.
2000: Kishioka S; Paronis C A; Lewis J W; Woods J H
Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys.
European journal of pharmacology 2000;391(3):289-97.
2000: Woods J H
Looking to the future of behavioral pharmacology while being attentive to its past.
Experimental and clinical psychopharmacology 2000;8(1):147-9.
2000: Ko M C; Tuchman J E; Johnson M D; Wiesenauer K; Woods J H
Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats.
Psychopharmacology 2000;148(2):180-5.
1999: Ko M C; Johnson M D; Butelman E R; Willmont K J; Mosberg H I; Woods J H
Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1999;291(3):1113-20.
1999: Traynor J R; Guo L; Coop A; Lewis J W; Woods J H
Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group.
The Journal of pharmacology and experimental therapeutics 1999;291(3):1093-9.
1999: Vivian J A; Liang Y J; Higley J D; Linnoila M; Woods J H
Oral self-administration of ethanol, phencyclidine, methadone, pentobarbital and quinine in rhesus monkeys.
Psychopharmacology 1999;147(2):113-24.
1999: Broadbear J H; Winger G; Woods J H
Glucocorticoid-reinforced responding in the rhesus monkey.
Psychopharmacology 1999;147(1):46-55.
1999: Neilan C L; Akil H; Woods J H; Traynor J R
Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists.
British journal of pharmacology 1999;128(3):556-62.
1999: Williams K L; Woods J H
Naltrexone reduces ethanol- and/or water-reinforced responding in rhesus monkeys: effect depends upon ethanol concentration.
Alcoholism, clinical and experimental research 1999;23(9):1462-7.
1999: Broadbear J H; Winger G; Woods J H
Cocaine-reinforced responding in rhesus monkeys: pharmacological attenuation of the hypothalamic-pituitary-adrenal axis response.
The Journal of pharmacology and experimental therapeutics 1999;290(3):1347-55.
1999: Lee K O; Akil H; Woods J H; Traynor J R
Differential binding properties of oripavines at cloned mu- and delta-opioid receptors.
European journal of pharmacology 1999;378(3):323-30.
1999: Johnson M D; Ko M; Choo K S; Traynor J R; Mosberg H I; Naughton N N; Woods J H
The effects of the phyllolitorin analogue [desTrp(3), Leu(8)]phyllolitorin on scratching induced by bombesin and related peptides in rats.
Brain research 1999;839(1):194-8.
1999: Vivian J A; Higley J D; Linnoila M; Woods J H
Oral ethanol self-administration in rhesus monkeys: behavioral and neurochemical correlates.
Alcoholism, clinical and experimental research 1999;23(8):1352-61.
1999: Rowlett J K; Winger G; Carter R B; Wood P L; Woods J H; Woolverton W L
Reinforcing and discriminative stimulus effects of the neuroactive steroids pregnanolone and Co 8-7071 in rhesus monkeys.
Psychopharmacology 1999;145(2):205-12.
1999: Broadbear J H; Winger G; Cicero T J; Woods J H
Effects of response contingent and noncontingent cocaine injection on hypothalamic-pituitary-adrenal activity in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1999;290(1):393-402.
1999: Vivian J A; DeYoung M B; Sumpter T L; Traynor J R; Lewis J W; Woods J H
kappa-Opioid receptor effects of butorphanol in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1999;290(1):259-65.
1999: Williams K L; Pakarinen E D; Woods J H
Quadazocine decreases responding reinforced by ethanol, sucrose, and phencyclidine fluid deliveries in rhesus monkeys: comparison to naltrexone's effects.
Psychopharmacology 1999;144(4):316-22.
1999: Broadbear J H; Winger G; Cicero T J; Woods J H
Effects of self-administered cocaine on plasma adrenocorticotropic hormone and cortisol in male rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1999;289(3):1641-7.
1999: Vivian J A; Sumpter T L; Woods J H
Further characterization of the quinine taste discrimination stimulus in rhesus monkeys: effects of inter-trial interval, number and distribution of test stimuli.
Behavioural pharmacology 1999;10(3):313-8.
1999: Ko M C; Woods J H
Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action.
Psychopharmacology 1999;143(3):322-6.
1999: Butelman E R; Vivian J A; Yu J; Kreek M J; Woods J H
Systemic effects of E-2078, a stabilized dynorphin A(1-8) analog, in rhesus monkeys.
Psychopharmacology 1999;143(2):190-6.
1999: Williams K L; Woods J H
Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys.
Alcoholism, clinical and experimental research 1999;23(4):708-15.
1999: Campbell C M; Butelman E R; Woods J H
Effects of (+)-HA-966, CGS-19755, phencyclidine, and dizocilpine on repeated acquisition of response chains in pigeons: systemic manipulation of central glycine sites.
The Journal of pharmacology and experimental therapeutics 1999;289(1):521-7.
1999: Ko M C; Butelman E R; Woods J H
Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1999;289(1):378-85.
1999: Remmers A E; Clark M J; Mansour A; Akil H; Woods J H; Medzihradsky F
Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor.
The Journal of pharmacology and experimental therapeutics 1999;288(2):827-33.
1999: Aspen J; Gatch M B; Woods J H
Training and characterization of a quinine taste discrimination in rhesus monkeys.
Psychopharmacology 1999;141(3):251-7.
1999: Pakarinen E D; Williams K L; Woods J H
Food restriction and sex differences on concurrent, oral ethanol and water reinforcers in juvenile rhesus monkeys.
Alcohol (Fayetteville, N.Y.) 1999;17(1):35-40.
1998: Williams K L; Woods J H
Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor.
Alcoholism, clinical and experimental research 1998;22(8):1634-9.
1998: Williams K L; Winger G; Pakarinen E D; Woods J H
Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys.
Psychopharmacology 1998;139(1-2):53-61.
1998: Woods J H
Problems and opportunities in regulation of benzodiazepines.
Journal of clinical pharmacology 1998;38(9):773-82.
1998: Husbands S M; Sadd J; Broadbear J H; Woods J H; Martin J; Traynor J R; Aceto M D; Bowman E R; Harris L S; Lewis J W
3-Alkyl ethers of clocinnamox: delayed long-term mu-antagonists with variable mu efficacy.
Journal of medicinal chemistry 1998;41(18):3493-8.
1998: Mets B; Winger G; Cabrera C; Seo S; Jamdar S; Yang G; Zhao K; Briscoe R J; Almonte R; Woods J H; Landry D W
A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(17):10176-81.
1998: Vivian J A; Kishioka S; Butelman E R; Broadbear J; Lee K O; Woods J H
Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.
The Journal of pharmacology and experimental therapeutics 1998;286(2):697-703.
1998: Lieberman P B; Woods J H; Young E A
The role of endogenous opioids in the luteinizing hormone surge in rats: studies with clocinnamox, a long-lasting opioid receptor antagonist.
European journal of pharmacology 1998;352(1):73-9.
1998: Alt A; Mansour A; Akil H; Medzihradsky F; Traynor J R; Woods J H
Stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding by endogenous opioids acting at a cloned mu receptor.
The Journal of pharmacology and experimental therapeutics 1998;286(1):282-8.
1998: Ko M C; Butelman E R; Woods J H
The role of peripheral mu opioid receptors in the modulation of capsaicin-induced thermal nociception in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1998;286(1):150-6.
1998: Butelman E R; Ko M C; Sobczyk-Kojiro K; Mosberg H I; Van Bemmel B; Zernig G; Woods J H
kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception.
The Journal of pharmacology and experimental therapeutics 1998;285(2):595-601.
1998: Ko M C; Butelman E R; Traynor J R; Woods J H
Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1998;285(2):518-26.
1998: Woods J H
Toward an account of individual differences in drug abuse.
NIDA research monograph 1998;169():2-5.
1998: France C P; Gerak L R; Rowlett J K; Woolverton W L; Winger G; Woods J H
Progress report from the testing program for stimulant and depressant drugs (1996).
NIDA research monograph 1998;178():429-39.
1998: Woods J H; Medzihradsky F; Smith C B; Winger G; Traynor J R
Evaluation of new compounds for opioid activity (1997).
NIDA research monograph 1998;178():408-28.
1998: Elmer G I; Pieper J O; Negus S S; Woods J H
Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests.
Pain 1998;75(1):129-40.
1998: Vanecek S A; Essman W D; Taylor D P; Woods J H
Discriminative stimulus characteristics of BMY 14802 in the pigeon.
The Journal of pharmacology and experimental therapeutics 1998;284(1):1-9.
1997: Clark M J; Emmerson P J; Mansour A; Akil H; Woods J H; Portoghese P S; Remmers A E; Medzihradsky F
Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.
The Journal of pharmacology and experimental therapeutics 1997;283(2):501-10.
1997: Paronis C A; Woods J H
Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats.
European journal of pharmacology 1997;337(1):27-34.
1997: Yu J; Butelman E R; Woods J H; Chait B T; Kreek M J
Dynorphin A (1-8) analog, E-2078, crosses the blood-brain barrier in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1997;282(2):633-8.
1997: Paronis C A; Woods J H
Ventilation in morphine-maintained rhesus monkeys. II: Tolerance to the antinociceptive but not the ventilatory effects of morphine.
The Journal of pharmacology and experimental therapeutics 1997;282(1):355-62.
1997: Paronis C A; Woods J H
Ventilation in morphine-maintained rhesus monkeys. I: Effects of naltrexone and abstinence-associated withdrawal.
The Journal of pharmacology and experimental therapeutics 1997;282(1):348-54.
1997: Woods J H; Winger G
Abuse liability of flunitrazepam.
Journal of clinical psychopharmacology 1997;17(3 Suppl 2):1S-57S.
1997: Yu J; Butelman E R; Woods J H; Chait B T; Kreek M J
Dynorphin A (1-8) analog, E-2078, is stable in human and rhesus monkey blood.
The Journal of pharmacology and experimental therapeutics 1997;280(3):1147-51.
1997: Zernig G; Lewis J W; Woods J H
Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception.
Psychopharmacology 1997;129(3):233-42.
1996: Butelman E R; Lewis J W; Woods J H
Methoclocinnamox: agonist and antagonist effects of a novel long-lasting opioid in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1996;279(2):934-8.
1996: Yu J; Butelman E R; Woods J H; Chait B T; Kreek M J
In vitro biotransformation of dynorphin A (1-17) is similar in human and rhesus monkey blood as studied by matrix-assisted laser desorption/ionization mass spectrometry.
The Journal of pharmacology and experimental therapeutics 1996;279(2):507-14.
1996: Jewett D C; Mosberg H I; Woods J H
Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5-enkephalin) in pigeons.
Psychopharmacology 1996;127(3):225-30.
1996: Acteo M D; Bowman E; Butelman E; Englis J A; Harrish L; Jacobson A E; Mattson M V; Medzihradsky F; Patrick G; Rowlett J K; Smith C B; Winger G; Woods J H; Woolverton W L
Zipeprol: preclinical assessment of abuse potential.
Drug and alcohol dependence 1996;42(2):93-104.
1996: Zernig G; Burke T; Lewis J W; Woods J H
Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
The Journal of pharmacology and experimental therapeutics 1996;279(1):23-31.
1996: Emmerson P J; Clark M J; Mansour A; Akil H; Woods J H; Medzihradsky F
Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.
The Journal of pharmacology and experimental therapeutics 1996;278(3):1121-7.
1996: Zernig G; Issaevitch T; Woods J H
Calculation of agonist efficacy, apparent affinity, and receptor population changes after administration of insurmountable antagonists: comparison of different analytical approaches.
Journal of pharmacological and toxicological methods 1996;35(4):223-37.
1996: Jewett D C; Butelman E R; Woods J H
Nitric oxide synthase inhibitors produce phencyclidine-like behavioral effects in pigeons.
Brain research 1996;715(1-2):25-31.
1996: Derrick I; Lewis J W; Moynihan H A; Broadbear J; Woods J H
Potential irreversible ligands for opioid receptors. Cinnamoyl derivatives of beta-naltrexamine.
The Journal of pharmacy and pharmacology 1996;48(2):192-6.
1996: Butelman E R; Negus S S; Lewis J W; Woods J H
Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys.
Psychopharmacology 1996;123(4):320-4.
1995: Butelman E R; France C P; Woods J H
Agonist and antagonist effects of dynorphin A-(1-13) in a thermal antinociception assay in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1995;275(1):374-80.
1995: Negus S S; Butelman E R; Gatch M B; Woods J H
Effects of morphine and ketorolac on thermal allodynia induced by prostaglandin E2 and bradykinin in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1995;274(2):805-14.
1995: France C P; Gerak L R; Flynn D; Winger G D; Medzihradsky F; Bagley J R; Brockunier L L; Woods J H
Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1995;274(1):17-28.
1995: Walker E A; Zernig G; Woods J H
Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure.
The Journal of pharmacology and experimental therapeutics 1995;273(3):1345-52.
1995: Butelman E R; Negus S S; Gatch M B; Chang K J; Woods J H
BW373U86, a delta-opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys.
European journal of pharmacology 1995;277(2-3):285-7.
1995: Woods J H; Winger G
Current benzodiazepine issues.
Psychopharmacology 1995;118(2):107-15; discussion 118, 120-1.
1995: Baron S P; Woods J H
Competitive and uncompetitive N-methyl-D-aspartate antagonist discriminations in pigeons: CGS 19755 and phencyclidine.
Psychopharmacology 1995;118(1):42-51.
1995: Butelman E R; Winger G; Zernig G; Woods J H
Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1995;272(2):845-53.
1995: Pakarinen E D; Woods J H; Moerschbaecher J M
Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist.
The Journal of pharmacology and experimental therapeutics 1995;272(2):552-9.
1995: Woods J H; Lewis J W; Winger G; Butelman E; Broadbear J; Zernig G
Methoclocinnamox: a mu partial agonist with pharmacotherapeutic potential for heroin abuse.
NIDA research monograph 1995;147():195-219.
1995: Zernig G; Issaevitch T; Broadbear J H; Burke T F; Lewis J W; Brine G A; Woods J H
Receptor reserve and affinity of mu opioid agonists in mouse antinociception: correlation with receptor binding.
Life sciences 1995;57(23):2113-25.
1994: Emmerson P J; Liu M R; Woods J H; Medzihradsky F
Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
The Journal of pharmacology and experimental therapeutics 1994;271(3):1630-7.
1994: Gerak L R; Butelman E R; Woods J H; France C P
Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1994;271(2):993-9.
1994: Burke T F; Woods J H; Lewis J W; Medzihradsky F
Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.
The Journal of pharmacology and experimental therapeutics 1994;271(2):715-21.
1994: Negus S S; Butelman E R; Chang K J; DeCosta B; Winger G; Woods J H
Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1994;270(3):1025-34.
1994: Broadbear J H; Negus S S; Butelman E R; de Costa B R; Woods J H
Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay.
Psychopharmacology 1994;115(3):311-9.
1994: Zernig G; Butelman E R; Lewis J W; Walker E A; Woods J H
In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
The Journal of pharmacology and experimental therapeutics 1994;269(1):57-65.
1994: France C P; Medzihradsky F; Woods J H
Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities.
The Journal of pharmacology and experimental therapeutics 1994;268(1):47-58.
1994: Patrick G A; Harris L S; Woolverton W L; Nader M A; Winger G; Woods J H
Progress report from the testing program for stimulant and depressant drugs (1993).
NIDA research monograph 1994;140():248-63.
1994: Woods J H; France C P; Medzihradsky F; Smith C B; Winger G D
Evaluation of new compounds for opioid activity annual report (1993).
NIDA research monograph 1994;140():196-247.
1993: Butelman E R; Negus S S; Ai Y; de Costa B R; Woods J H
Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1993;267(3):1269-76.
1993: Negus S S; Burke T F; Medzihradsky F; Woods J H
Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.
The Journal of pharmacology and experimental therapeutics 1993;267(2):896-903.
1993: Comer S D; Hoenicke E M; Sable A I; McNutt R W; Chang K J; De Costa B R; Mosberg H I; Woods J H
Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.
The Journal of pharmacology and experimental therapeutics 1993;267(2):888-95.
1993: Comer S D; McNutt R W; Chang K J; De Costa B R; Mosberg H I; Woods J H
Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.
The Journal of pharmacology and experimental therapeutics 1993;267(2):866-74.
1993: Walker E A; Butelman E R; DeCosta B R; Woods J H
Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.
The Journal of pharmacology and experimental therapeutics 1993;267(1):280-6.
1993: Negus S S; Butelman E R; Al Y; Woods J H
Prostaglandin E2-induced thermal hyperalgesia and its reversal by morphine in the warm-water tail-withdrawal procedure in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1993;266(3):1355-63.
1993: Skjoldager P; Winger G; Woods J H
Effects of GBR 12909 and cocaine on cocaine-maintained behavior in rhesus monkeys.
Drug and alcohol dependence 1993;33(1):31-9.
1993: Butelman E R; Woods J H
Effects of clonidine, dexmedetomidine and xylazine on thermal antinociception in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1993;264(2):762-9.
1993: Baron S P; Woods J H
Dipsogenic effects of excitatory amino acid agonists in pigeons.
The Journal of pharmacology and experimental therapeutics 1993;264(2):918-21.
1993: Butelman E R; France C P; Woods J H
Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1993;264(1):145-51.
1993: Woods J H; France C P; Medzihradsky F; Smith C B; Winger G D
Evaluation of new compounds for opioid activity, 1992.
NIDA research monograph 1993;132():517-78.
1993: Woolverton W L; Nader M A; Winger G; Woods J H; Patrick G A; Harris L S
Progress report from the testing program for stimulant and depressant drug (1992).
NIDA research monograph 1993;132():579-94.
1992: Lu Y; France C P; Woods J H
Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists.
The Journal of pharmacology and experimental therapeutics 1992;263(2):499-504.
1992: Winger G; France C P; Woods J H; Smith C B; Medzihradsky F; Iorio M A
Opioid and non-opioid effects of novel butyrophenone analogues.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1992;7(3):177-87.
1992: Hoenicke E M; Vanecek S A; Woods J H
The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
The Journal of pharmacology and experimental therapeutics 1992;263(1):276-84.
1992: Comer S D; Burke T F; Lewis J W; Woods J H
Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
The Journal of pharmacology and experimental therapeutics 1992;262(3):1051-6.
1992: Woods J H; Winger G; France C P
Use of in vivo apparent pA2 analysis in assessment of opioid abuse liability.
Trends in pharmacological sciences 1992;13(7):282-6.
1992: Woods J H; Katz J L; Winger G
Benzodiazepines: use, abuse, and consequences.
Pharmacological reviews 1992;44(2):151-347.
1992: Winger G; Skjoldager P; Woods J H
Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1992;261(1):311-7.
1992: Bertalmio A J; Medzihradsky F; Winger G; Woods J H
Differential influence of N-dealkylation on the stimulus properties of some opioid agonists.
The Journal of pharmacology and experimental therapeutics 1992;261(1):278-84.
1992: Woods J H; Medzihradsky F; Smith C B; Winger G D; France C P
Evaluation of new compounds for opioid activity (1991).
NIDA research monograph 1992;119():559-603.
1992: Woods J H; France C P; Winger G D
Behavioral pharmacology of buprenorphine: issues relevant to its potential in treating drug abuse.
NIDA research monograph 1992;121():12-27.
1992: France C P; Winger G; Seggel M R; Rice K C; Woods J H
Pharmacological profile of a potent, efficacious fentanyl derivative in rhesus monkeys.
Psychopharmacology 1992;109(3):291-8.
1992: Winger G; Woods J H; Patrick G A; Powell L J; Harris L S; Nader M A; Woolverton W L
Progress report from the Testing Program for Stimulant and Depressant Drugs (1991).
NIDA research monograph 1992;119():625-39.
1992: Patrick G A; Harris L S; Nader M A; Woolverton W L; Winger G; Woods J H
Progress report from the Testing Program for Stimulant and Depressant Drugs (1990).
NIDA research monograph 1992;119():604-24.
1992: Bertalmio A J; Woods J H
Discriminative stimulus effects of cyclorphan: selective antagonism with naltrexone.
Psychopharmacology 1992;106(2):189-94.
1991: Walker E A; Yamamoto T; Hollingsworth P J; Smith C B; Woods J H
Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
The Journal of pharmacology and experimental therapeutics 1991;259(2):772-82.
1991: Skjoldager P; Winger G; Woods J H
Analysis of fixed-ratio behavior maintained by drug reinforcers.
Journal of the experimental analysis of behavior 1991;56(2):331-43.
1991: Yamamoto T; Walker E A; Woods J H
Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
The Journal of pharmacology and experimental therapeutics 1991;258(3):999-1007.
1991: France C P; Winger G; Medzihradsky F; Seggel M R; Rice K C; Woods J H
Mirfentanil: pharmacological profile of a novel fentanyl derivative with opioid and nonopioid effects.
The Journal of pharmacology and experimental therapeutics 1991;258(2):502-10.
1991: France C P; Moerschbaecher J M; Woods J H
MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination.
The Journal of pharmacology and experimental therapeutics 1991;257(2):727-34.
1991: Woods J H; Katz J L; Winger G D
Restricting benzodiazepine prescribing.
Lancet 1991;337(8736):295.
1991: Nader M A; Winger G; Woods J H; Woolverton W L
Discriminative and reinforcing effects of brotizolam in rhesus monkeys.
Psychopharmacology 1991;103(2):166-71.
1991: Comer S D; France C P; Woods J H
Training dose: influences in opioid drug discrimination.
NIDA research monograph 1991;(116):145-61.
1990: France C P; Lu Y; Woods J H
Interactions between N-methyl-D-aspartate and CGS 19755 administered intramuscularly and intracerebroventricularly in pigeons.
The Journal of pharmacology and experimental therapeutics 1990;255(3):1271-7.
1990: France C P; Winger G D; Woods J H
Analgesic, anesthetic, and respiratory effects of the competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 in rhesus monkeys.
Brain research 1990;526(2):355-8.
1990: France C P; Woods J H
Discriminative stimulus effects of opioid agonists in morphine-dependent pigeons.
The Journal of pharmacology and experimental therapeutics 1990;254(2):626-32.
1990: Thurkauf A; de Costa B; Mattson M V; France C P; Price M T; Olney J W; Woods J H; Jacobson A E; Rice K C
Synthesis, phencyclidine-like pharmacology, and antiischemic potential of meta-substituted 1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridines.
Journal of medicinal chemistry 1990;33(8):2211-5.
1990: Koek W; Woods J H; Colpaert F C
N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis.
The Journal of pharmacology and experimental therapeutics 1990;253(3):1017-25.
1990: Woods J H
Abuse liability and the regulatory control of therapeutic drugs: untested assumptions.
Drug and alcohol dependence 1990;25(2):229-33.
1990: France C P; de Costa B R; Jacobson A E; Rice K C; Woods J H
Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone.
The Journal of pharmacology and experimental therapeutics 1990;252(2):600-4.
1990: Smith C B; Medzihradsky F; Hollingsworth P J; DeCosta B; Rice K C; Woods J H
Nor-binaltorphimine is a reversible, noncompetitive opioid antagonist in the mouse vas deferens with high affinity for kappa receptors in monkey brain membranes.
Progress in clinical and biological research 1990;328():65-8.
1990: France C P; Woods J H
Respiratory effects of receptor-selective opioids in rhesus monkeys.
Progress in clinical and biological research 1990;328():295-8.
1990: Woods J H; Medzihradsky F; Smith C B; Winger G D; France C P
Evaluation of new compounds for opioid activity (1990).
NIDA research monograph 1990;105():682-724.
1989: Bertalmio A J; Woods J H
Reinforcing effect of alfentanil is mediated by mu opioid receptors: apparent pA2 analysis.
The Journal of pharmacology and experimental therapeutics 1989;251(2):455-60.
1989: Winger G; Palmer R K; Woods J H
Drug-reinforced responding: rapid determination of dose-response functions.
Drug and alcohol dependence 1989;24(2):135-42.
1989: Koek W; Colpaert F C; Woods J H; Kamenka J M
The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
The Journal of pharmacology and experimental therapeutics 1989;250(3):1019-27.
1989: France C P; Woods J H
Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1989;250(3):937-43.
1989: Rothman R B; France C P; Bykov V; De Costa B R; Jacobson A E; Woods J H; Rice K C
Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
European journal of pharmacology 1989;167(3):345-53.
1989: France C P; Snyder A M; Woods J H
Analgesic effects of phencyclidine-like drugs in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1989;250(1):197-201.
1989: Aceto M D; Bowman E R; May E L; Harris L S; Woods J H; Smith C B; Medzihradsky F; Jacobson A E
Very long-acting narcotic antagonists: the 14 beta-p-substituted cinnamoylaminomorphinones and their partial mu agonist codeinone relatives.
Arzneimittel-Forschung 1989;39(5):570-5.
1989: France C P; Woods J H; Ornstein P
The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects.
European journal of pharmacology 1989;159(2):133-9.
1989: France C P; Woods J H
Naltrexone discrimination in morphine-treated monkeys.
NIDA research monograph 1989;95():298-9.
1989: Woods J H; Medzihradsky F; Smith C B; Winger G D; France C P
1989 Annual Report, evaluation of new compounds for opioid activity.
NIDA research monograph 1989;95():632-79.
1989: Woods J H; DeCosta B; Jacobson A E; Rice K C; Medzihradsky F; Smith C B; Comer S; France C P; Winger G
Delta opioid receptor selective alkaloid agonists and antagonists.
NIDA research monograph 1989;95():300-1.
1988: Woods J H; Katz J L; Winger G
Use and abuse of benzodiazepines. Issues relevant to prescribing.
JAMA : the journal of the American Medical Association 1988;260(23):3476-80.
1988: Koek W; Woods J H
2-Amino-6-trifluoromethoxy benzothiazole (PK 26124), a proposed antagonist of excitatory amino acid neurotransmission, does not produce phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
Neuropharmacology 1988;27(7):771-5.
1988: Koek W; Woods J H; Winger G D
MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1988;245(3):969-74.
1988: France C P; Woods J H
Acute supersensitivity to the discriminative stimulus effects of naltrexone in pigeons.
The Journal of pharmacology and experimental therapeutics 1988;244(2):599-605.
1988: Woods J; Medzihradsky F; Smith C; Winger G; Gmerek D
Evaluation of new compounds for opioid activity: 1987 annual report.
NIDA research monograph 1988;81():543-90.
1988: Woods J H; Bertalmio A J; Young A M; Essman W D; Winger G
Receptor mechanisms of opioid drug discrimination.
Psychopharmacology series 1988;4():95-106.
1987: Woods J H; Katz J L; Winger G
Abuse liability of benzodiazepines.
Pharmacological reviews 1987;39(4):251-413.
1987: Woods J H; Winger G
Behavioral characterization of opioid mixed agonist-antagonists.
Drug and alcohol dependence 1987;20(4):303-15.
1987: Bertalmio A J; Woods J H
Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.
The Journal of pharmacology and experimental therapeutics 1987;243(2):591-7.
1987: Jacobson A E; Harrison E A; Mattson M V; Rafferty M F; Rice K C; Woods J H; Winger G; Solomon R E; Lessor R A; Silverton J V
Enantiomeric and diastereomeric dioxadrols: behavioral, biochemical and chemical determination of the configuration necessary for phencyclidine-like properties.
The Journal of pharmacology and experimental therapeutics 1987;243(1):110-7.
1987: Koek W; Woods J H; Mattson M V; Jacobson A E; Mudar P J
Excitatory amino acid antagonists induce a phencyclidine-like catalepsy in pigeons: structure-activity studies.
Neuropharmacology 1987;26(9):1261-5.
1987: Dykstra L A; Gmerek D E; Winger G; Woods J H
Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects.
The Journal of pharmacology and experimental therapeutics 1987;242(2):413-20.
1987: Gmerek D E; Dykstra L A; Woods J H
Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration.
The Journal of pharmacology and experimental therapeutics 1987;242(2):428-36.
1987: Dykstra L A; Gmerek D E; Winger G; Woods J H
Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.
The Journal of pharmacology and experimental therapeutics 1987;242(2):421-7.
1987: France C P; Woods J H
Morphine, saline and naltrexone discrimination in morphine-treated pigeons.
The Journal of pharmacology and experimental therapeutics 1987;242(1):195-202.
1987: France C P; Adams J U; Woods J H
Comparison of naltrexone and quaternary naltrexone after systemic and intracerebroventricular administration in pigeons.
Neuropharmacology 1987;26(6):541-8.
1987: Woods J H; Smith C B; Medzihradsky F; Winger G D; Gmerek D E
Evaluation of new compounds for opioid activity: 1986 annual report.
NIDA research monograph 1987;76():448-84.
1987: France C P; Woods J H
Beta-funaltrexamine antagonizes the discriminative stimulus effects of morphine but not naltrexone in pigeons.
Psychopharmacology 1987;91(2):213-6.
1987: Koek W; Woods J H; Jacobson A E; Rice K C
Phencyclidine (PCP)-like discriminative stimulus effects of metaphit and of 2-amino-5-phosphonovalerate in pigeons: generality across different training doses of PCP.
Psychopharmacology 1987;93(4):437-42.
1987: Koek W; Woods J H; Ornstein P
A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats.
Psychopharmacology 1987;91(3):297-304.
1986: Gmerek D E; Woods J H
Kappa receptor mediated opioid dependence in rhesus monkeys.
Life sciences 1986;39(11):987-92.
1986: Koek W; Woods J H; Ornstein P
Phencyclidine-like behavioral effects in pigeons induced by systemic administration of the excitatory amino acid antagonist, 2-amino-5-phosphonovalerate.
Life sciences 1986;39(11):973-8.
1986: Dykstra L A; Woods J H
A tail withdrawal procedure for assessing analgesic activity in rhesus monkeys.
Journal of pharmacological methods 1986;15(3):263-9.
1986: Koek W; Woods J H; Jacobson A E; Rice K C; Lessor R A
Metaphit, a proposed phencyclidine receptor acylator: phencyclidine-like behavioral effects and evidence of absence of antagonist activity in pigeons and in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1986;237(2):386-92.
1986: Takada K; Winger G; Cook J; Larscheid P; Woods J H
Discriminative and aversive properties of beta-carboline-3-carboxylic acid ethyl ester, a benzodiazepine receptor inverse agonist, in rhesus monkeys.
Life sciences 1986;38(11):1049-56.
1986: Young E A; Walker J M; Lewis M E; Houghten R A; Woods J H; Akil H
[3H]dynorphin A binding and kappa selectivity of prodynorphin peptides in rat, guinea-pig and monkey brain.
European journal of pharmacology 1986;121(3):355-65.
1986: Koek W; Kleer E; Mudar P J; Woods J H
Phencyclidine-like catalepsy induced by the excitatory amino acid antagonist DL-2-amino-5-phosphonovalerate.
Behavioural brain research 1986;19(3):257-9.
1986: Gmerek D E; Cowan A; Woods J H
Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats.
The Journal of pharmacology and experimental therapeutics 1986;236(1):8-13.
1986: Koek W; Woods J H
Response repetition in pigeons: pharmacological and behavioral specificity.
Psychopharmacology 1986;90(4):475-81.
1986: Woods J H; Medzihradsky F; Smith C B; Winger G D; Gmerek D E
Evaluation of new compounds for opioid activity (1985).
NIDA research monograph 1986;67():453-89.
1986: Takada K; Winger G D; Cook J; Larscheid P; Woods J H
Discriminative and aversive stimulus effects of beta-carboline ethyl ester in rhesus monkeys.
NIDA research monograph 1986;67():119-24.
1986: Smith C B; Medzihradsky F; Woods J H
Dihydromorphine-peptide hybrids have mu receptor antagonistic and delta receptor agonistic activity on the mouse vas deferens and bind with high affinity to opioid receptors in rat brain.
NIDA research monograph 1986;75():189-92.
1985: France C P; Adams J U; Woods J H
Intracerebroventricular drug administration in pigeons.
Pharmacology, biochemistry, and behavior 1985;23(5):731-6.
1985: France C P; Woods J H
Antagonistic and rate-suppressing effects of opioid antagonists in the pigeon.
The Journal of pharmacology and experimental therapeutics 1985;235(2):442-7.
1985: Gmerek D E; Woods J H
Effects of beta-funaltrexamine in normal and morphine-dependent rhesus monkeys: observational studies.
The Journal of pharmacology and experimental therapeutics 1985;235(2):296-301.
1985: Aceto M D; Harris L S; Woods J H; Katz J L; Smith C B; Medzihradsky F; Jacobson A E; Shiotani S
Pharmacological actions of the racemic and the enantiomeric 1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz azo nines (C-homobenzomorphans).
Japanese journal of pharmacology 1985;39(1):7-19.
1985: Koek W; Head R; Holsztynska E J; Woods J H; Domino E F; Jacobson A E; Rafferty M F; Rice K C; Lessor R A
Effects of metaphit, a proposed phencyclidine receptor acylator, on catalepsy in pigeons.
The Journal of pharmacology and experimental therapeutics 1985;234(3):648-53.
1985: France C P; Woods J H
Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
The Journal of pharmacology and experimental therapeutics 1985;234(1):81-9.
1985: Winger G; Woods J H
Comparison of fixed-ratio and progressive-ratio schedules of maintenance of stimulant drug-reinforced responding.
Drug and alcohol dependence 1985;15(1-2):123-30.
1985: Woods J H; Gmerek D E
Substitution and primary dependence studies in animals.
Drug and alcohol dependence 1985;14(3-4):233-47.
1985: France C P; Woods J H
Effects of morphine, naltrexone, and dextrorphan in untreated and morphine-treated pigeons.
Psychopharmacology 1985;85(3):377-82.
1984: Smith C B; Bennett-Kelly L; Woods J H
Comparison of "selective" opiate receptor antagonists on the isolated mouse vas deferens.
Neuropeptides 1984;5(1-3):161-4.
1984: Koek W; Woods J H; Rice K C; Jacobson A E; Huguenin P N; Burke T R
Phencyclidine-induced catalepsy in pigeons: specificity and stereoselectivity.
European journal of pharmacology 1984;106(3):635-8.
1984: Herling S; Valentino R J; Solomon R E; Woods J H
Narcotic discrimination in pigeons: antagonism by naltrexone.
European journal of pharmacology 1984;105(1-2):137-42.
1984: France C P; Jacobson A E; Woods J H
Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine.
The Journal of pharmacology and experimental therapeutics 1984;230(3):652-7.
1984: Medzihradsky F; Dahlstrom P J; Woods J H; Fischel S V; Mitsos S E
Resolution in the receptor binding of putative mu and kappa opiates.
Life sciences 1984;34(22):2129-38.
1984: Young A M; Stephens K R; Hein D W; Woods J H
Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids.
The Journal of pharmacology and experimental therapeutics 1984;229(1):118-26.
1984: France C P; Jacobson A E; Woods J H
Irreversible and reversible narcotic agonists: discriminative and analgesic effects of buprenorphine, oxymorphazone, and morphine.
NIDA research monograph 1984;49():136-42.
1984: Woods J H
Progress report on the stimulant-depressant abuse liability evaluation project.
NIDA research monograph 1984;49():59-62.
1984: Woods J H; Winger G D; Medzihradsky F; Smith C B; Katz J L
Evaluation of new compounds for opioid activity (1983).
NIDA research monograph 1984;49():361-7.
1984: Gmerek D; Woods J H
Effects of b-FNA in drug-naive and morphine-dependent rhesus monkeys.
NIDA research monograph 1984;55():99-105.
1984: Woods J H; Winger G D; Medzihradsky F; Smith C B; Gmerek D; Aceto M D; Harris L S; May E L; Balster R L; Slifer B L
Evaluation of new compounds for opioid activity in rhesus monkey, rat, and mouse (1984)
NIDA research monograph 1984;55():309-93.
1983: Herling S; Solomon R E; Woods J H
Discriminative stimulus effects of dextrorphan in pigeons.
The Journal of pharmacology and experimental therapeutics 1983;227(3):723-31.
1983: Valentino R J; Katz J L; Medzihradsky F; Woods J H
Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists.
Life sciences 1983;32(25):2887-96.
1983: Woods J H; Katz J L; Medzihradsky F; Smith C B; Winger G D
Evaluation of new compounds for opioid activity: 1982 annual report.
NIDA research monograph 1983;43():457-511.
1983: Valentino R J; Herling S; Woods J H
Discriminative stimulus effects of naltrexone in narcotic-naive and morphine-treated pigeons.
The Journal of pharmacology and experimental therapeutics 1983;224(2):307-13.
1983: Woods J H
Experimental abuse liability assessment of benzodiazepines.
Journal of psychoactive drugs 1983;15(1-2):61-5.
1983: Woods J H
Some thoughts on the relations between animal and human drug-taking.
Progress in neuro-psychopharmacology & biological psychiatry 1983;7(4-6):577-84.
1983: Gmerek D E; Katz J L; France C P; Woods J H
Systemic and intracerebroventricular effects of opioid peptides in withdrawn morphine-dependent rhesus monkeys.
Life sciences 1983;33 Suppl 1():361-4.
1983: Woods J H; Young A M; Medzihradsky F; Smith C B; Aceto M D; Harris L S; Jacobson A E
Zomepirac: preclinical narcotic abuse liability evaluation.
Arzneimittel-Forschung 1983;33(2):218-22.
1982: Solomon R E; Herling S; Domino E F; Woods J H
Discriminative stimulus effects of N-substituted analogs of phencyclidine in rhesus monkeys.
Neuropharmacology 1982;21(12):1329-36.
1982: Katz J L; Woods J H; Winger G D; Jacobson A E
Compounds of novel structure having kappa-agonist behavioral effects in rhesus monkeys.
Life sciences 1982;31(20-21):2375-8.
1982: Falk J L; Schuster C R; Bigelow G E; Woods J H
Progress and needs in the experimental analysis of drug and alcohol dependence.
The American psychologist 1982;37(10):1124-7.
1982: Solomon R E; Herling S; Woods J H
Discriminative stimulus effects of monohydroxylated phencyclidine metabolites in Rhesus monkeys.
European journal of pharmacology 1982;82(3-4):233-7.
1982: Bertalmio A J; Herling S; Hampton R Y; Winger G; Woods J H
A procedure for rapid evaluation of the discriminative stimulus effects of drugs.
Journal of pharmacological methods 1982;7(4):289-99.
1982: Hampton R Y; Medzihradsky F; Woods J H; Dahlstrom P J
Stereospecific binding of 3H-phencyclidine in brain membranes.
Life sciences 1982;30(25):2147-54.
1982: Young A M; Woods J H
Limitations on the antagonistic actions of opioid antagonists.
Federation proceedings 1982;41(7):2333-8.
1982: Woods J H; Katz J L; Medzihradsky F; Smith C B; Young A M; Winger G D
1981 annual report: evaluation of new compounds for opioid activity.
NIDA research monograph 1982;41():381-451.
1982: Jacobson A E; Schmidhammer H; Hsu F L; Rozwadowska M D; Atwell L; Brossi A; Aceto M D; Harris L S; Katz J L; Woods J H; Medzihradsky F
Structure-activity relationships of oxygenated morphinans. III. An exploration of the effect of the aromatic oxygen and 6-keto group on antinociceptive activity, receptor affinity, and narcotic antagonism.
NIDA research monograph 1982;41():86-92.
1982: Woods J H; Young A M; Herling S
Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys.
Federation proceedings 1982;41(2):221-7.
1982: Herling S; Hein D W; Nemeth M A; Valentino R J; Woods J H
Discriminative stimulus, antagonist, and rate-decreasing effects of cyclorphan: multiple modes of action.
Life sciences 1982;30(4):331-41.
1981: Young A M; Woods J H
Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories.
The Journal of pharmacology and experimental therapeutics 1981;218(3):720-7.
1981: Young A M; Katz J L; Woods J H
Behavioral effects of levonantradol and nantradol in the rhesus monkey.
Journal of clinical pharmacology 1981;21(8-9 Suppl):348S-360S.
1981: Hein D W; Young A M; Herling S; Woods J H
Pharmacological analysis of the discriminative stimulus characteristics of ethylketazocine in the rhesus monkey.
The Journal of pharmacology and experimental therapeutics 1981;218(1):7-15.
1981: Young A M; Herling S; Woods J H
History of drug exposure as a determinant of drug self-administration.
NIDA research monograph 1981;37():75-88.
1981: Woods J H; Schuster C R; Hartel C R
Behavioral effects of thebaine in the rhesus monkey.
Pharmacology, biochemistry, and behavior 1981;14(6):805-9.
1981: Valentino R J; Herling S; Woods J H; Medzihradsky F; Merz H
Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists.
The Journal of pharmacology and experimental therapeutics 1981;217(3):652-9.
1981: Valentino R J; Smith C B; Woods J H
Physiological and behavioral approaches to the study of the quasi-morphine withdrawal syndrome.
Federation proceedings 1981;40(5):1502-7.
1981: Herling S; Woods J H
Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions.
Life sciences 1981;28(14):1571-84.
1981: Woods J H; Medzihradsky F; Smith C B; Young A M; Swain H H
Annual report: evaluation of new compounds for opioid activity (1980).
NIDA research monograph 1981;34():327-66.
1981: Young A M; Herling S; Winger G D; Woods J H
Comparison of discriminative and reinforcing effects of ketamine and related compounds in the rhesus monkey.
NIDA research monograph 1981;34():173-9.
1981: Woods J H; Katz J L; Young A M; Medzihradsky F; Smith C B
Correlations among certain behavioral, physiological, and biochemical effects of narcotic agonists.
NIDA research monograph 1981;34():43-57.
1981: Valentino R J; Herling S; Woods J H
The relationship between the acute behavioral effects of narcotic antagonists and the narcotic-dependent state [proceedings]
Psychopharmacology bulletin 1981;17(1):51-4.
1981: Young A M; Swain H H; Woods J H
Comparison of opioid agonists in maintaining responding and in suppressing morphine withdrawal in rhesus monkeys.
Psychopharmacology 1981;74(4):329-35.
1981: Herling S; Coale E H; Hein D W; Winger G; Woods J H
Similarity of the discriminative stimulus effects of ketamine, cyclazocine, and dextrorphan in the pigeon.
Psychopharmacology 1981;73(3):286-91.
1981: Herling S; Woods J H
Discriminative stimulus effects of etorphine in Rhesus monkeys.
Psychopharmacology 1981;72(3):265-7.
1980: Herling S; Woods J H
Chlorpromazine effects on cocaine-reinforced responding in rhesus monkeys: reciprocal modification of rate-altering effects of the drugs.
The Journal of pharmacology and experimental therapeutics 1980;214(2):354-61.
1980: Herling S; Coale E H; Valentino R J; Hein D W; Woods J H
Narcotic discrimination in pigeons.
The Journal of pharmacology and experimental therapeutics 1980;214(1):139-46.
1980: Woods J H
Narcotic-reinforced responding: a rapid evaluation procedure.
Drug and alcohol dependence 1980;5(3):223-30.
1980: Abelson J S; Woods J H
Effects of apomorphine on elicited and operant pecking in pigeons.
Psychopharmacology 1980;71(3):237-41.
1980: Young A M; Woods J H
Behavior maintained by intravenous injection of codeine, cocaine, and etorphine in the rhesus macaque and the pigtail macaque.
Psychopharmacology 1980;70(3):263-71.
1980: Moody D B; Winger G; Woods J H; Stebbins W C
Effect of ethanol and of noise on reaction time in the monkey: variation with stimulus level.
Psychopharmacology 1980;69(1):45-51.
1979: Valentino R J; Smith C B; Woods J H
An unusual benzazocine elicits acetylcholine release in the isolated guinea pig ileum.
Nature 1979;281(5730):370-2.
1979: Herling S; Downs D A; Woods J H
Cocaine, d-amphetamine, and pentobarbital effects on responding maintained by food or cocaine in rhesus monkeys.
Psychopharmacology 1979;64(3):261-9.
1979: Swain H H; Woods J H; Medzihradsky F; Smith C B; Fly C L
Annual report: evaluation of new compounds for opioid activity (1979).
NIDA research monograph 1979;27():356-98.
1979: Woods J H; Herling S; Valentino R J; Hein D W; Coale E H
Narcotic drug discriminations by rhesus monkeys and pigeons.
NIDA research monograph 1979;27():128-34.
1978: Tepper P; Woods J H
Changes in locomotor activity and naloxone-induced jumping in mice produced by WIN 35, 197-2 (ethylketazocine) and morphine.
Psychopharmacology 1978;58(2):125-9.
1978: Karoly A J; Winger G; Ikomi F; Woods J H
The reinforcing property of ethanol in the rhesus monkey II. Some variables related to the maintenance of intravenous ethanol-reinforced responding.
Psychopharmacology 1978;58(1):19-25.
1978: Tessel R E; Woods J H
meta Substituted N-ethylamphetamine self injection responding in the rhesus monkey: structure-activity relationships.
The Journal of pharmacology and experimental therapeutics 1978;205(2):274-81.
1977: Woods J H
Alcohol intoxication and withdrawal--IIIb. Studies in alcohol dependence: introduction to the papers on operant conditioning and alcohol intake.
Advances in experimental medicine and biology 1977;85B():421-2.
1976: Carney J M; Llewellyn M E; Woods J H
Variable interval responding maintained by intravenous codeine and ethanol injections in the rhesus monkey.
Pharmacology, biochemistry, and behavior 1976;5(5):577-52.
1976: Downs D A; Woods J H
Morphine, pentazocine and naloxone effects on responding under a multiple schedule of reinforcement in rhesus monkeys and pigeons.
The Journal of pharmacology and experimental therapeutics 1976;196(2):298-306.
1976: Llewellyn M E; Iglauer C; Woods J H
Relative reinforcer magnitude under a nonindependent concurrent schedule of cocaine reinforcement in rhesus monkeys.
Journal of the experimental analysis of behavior 1976;25(1):81-91.
1975: Winger G; Stitzer M L; Woods J H
Barbiturate-reinforced responding in rhesus monkeys: comparisons of drugs with different durations of action.
The Journal of pharmacology and experimental therapeutics 1975;195(3):505-14.
1975: Downs D A; Woods J H
Naloxone as a negative reinforcer in rhesus monkeys: effects of dose, schedule, and narcotic regimen.
Pharmacological reviews 1975;27(3):397-406.
1975: Iglauer C; Llewellyn M E; Woods J H
Concurrent schedules of cocaine injection in rhesus monkeys: dose variations under independent and non-independent variable-interval procedures.
Pharmacological reviews 1975;27(3):367-83.
1975: Tessel R E; Woods J H
Fenfluramine and N-ethyl amphetamine: comparison of the reinforcing and rate-decreasing actions in the rhesus monkey.
Psychopharmacologia 1975;43(3):239-44.
1975: Woods J H; Downs D A; Carney J
Behavioral functions of narcotic antagonists: response-drug contingencies.
Federation proceedings 1975;34(9):1777-84.
1975: Downs D A; Woods J H
Food- and drug-reinforced responding: effects of DITA and d-amphetamine.
Psychopharmacologia 1975;43(1):13-7.
1975: Downs D A; Woods J H
Fixed-ratio escape and avoidance-escape from naloxone in morphine-dependent monkeys: effects of naloxone dose and morphine pretreatment.
Journal of the experimental analysis of behavior 1975;23(3):415-27.
1975: Tessel R E; Woods J H; Counsell R E; Basmadjian G P
Structure-activity relationships between meta-substituted N-ethylamphetamines and isolated guinea-pig atrial rate.
The Journal of pharmacology and experimental therapeutics 1975;192(2):319-26.
1975: Tessel R E; Woods J H; Counsell R E; Lu M
Structure-activity relationships between meta-substituted N-ethylamphetamines and locomotor activity in mice.
The Journal of pharmacology and experimental therapeutics 1975;192(2):310-8.
1974: Downs D A; Woods J H
Codeine- and cocaine-reinforced responding in rhesus monkeys: effects of dose on response rates under a fixed-ratio schedule.
The Journal of pharmacology and experimental therapeutics 1974;191(1):179-88.
1974: Woods J H; Tessel R E
Fenfluramine: amphetamine congener that fails to maintain drug-taking behavior in the rhesus monkey.
Science (New York, N.Y.) 1974;185(156):1067-9.
1974: Iglauer C; Woods J H
Concurrent performances: reinforcement by different doses of intravenous cocaine in rhesus monkeys.
Journal of the experimental analysis of behavior 1974;22(1):179-96.
1974: Woods J H; Winger G D
Alcoholism and animals.
Preventive medicine 1974;3(1):49-60.
1973: Winger G D; Woods J H
The reinforcing property of ethanol in the rhesus monkey. I. Initiation, maintenance and termination of intravenous ethanol-reinforced responding.
Annals of the New York Academy of Sciences 1973;215():162-5.
1971: Goldberg S R; Woods J H; Schuster C R
Nalorphine-induced changes in morphine self-administration in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 1971;176(2):464-71.
1969: Goldberg S R; Woods J H; Schuster C R
Morphine: conditioned increases in self-administration in rhesus monkeys.
Science (New York, N.Y.) 1969;166(910):1306-7.
1966: Schuster C R; Woods J H
Schedule-induced polydipsia in the rhesus monkey.
Psychological reports 1966;19(3):823-8.
1966: Schuster C R; Dockens W S; Woods J H
Behavioral variables affecting the development of amphetamine tolerance.
Psychopharmacologia 1966;9(2):170-82.

Sign-in to see more